Resveratrol Inhibits Hepatic Stellate Cell Activation via the Hippo Pathway
Authors:
Open Access
- 1 January 2021
- journal article
- research article
- Published by Wiley in Mediators of Inflammation
- Vol. 2021 (1)
Abstract
Liver fibrosis, which results from chronic liver injury due to factors such as chronic alcohol consumption, hepatitis virus infections, and immune attacks, is marked by excessive deposition of extracellular matrix (ECM). Resveratrol (Res), a polyphenol phytoalexin, has been demonstrated to show anti‐inflammatory, antioxidative, antiproliferative, and chemopreventive activities. In recent years, Res has been found to inhibit liver fibrosis. Enhanced Hippo pathway activation has also been reported to inhibit tumor progression and liver fibrosis. In the present study, the role of the Hippo pathway in mediating the effects of Res on hepatic stellate cells (HSCs) was examined. We found that Res significantly suppresses HSC proliferation, reducing the cell index. Res induced HSC inactivation, reducing collagen deposition and α‐smooth muscle actin (α‐SMA) expression. In addition, Res contributed to HSC apoptosis, upregulating Bax and downregulating Bcl‐2 expression. Notably, the Hippo pathway was involved in the Res‐mediated suppression of HSC activation. Res enhanced the activation of the Hippo pathway and reduced yes‐associated protein (YAP) and transcriptional coactivator with the PDZ‐binding motif (TAZ) expression. Interestingly, the YAP overexpression inhibited Res‐induced HSC inactivation and apoptosis. In conclusion, these results demonstrate that Res inhibits HSC activation, at least in part, via the Hippo pathway. The present study indicates a new antifibrotic mechanism of Res and provides novel insights into Hippo‐mediated HSC apoptosis and HSC activation in liver fibrosis.Keywords
Funding Information
- National Natural Science Foundation of China (81873576)
This publication has 33 references indexed in Scilit:
- Resveratrol Regulates Activated Hepatic Stellate Cells by Modulating NF‐κB and the PI3K/Akt Signaling PathwayJournal of Food Science, 2015
- Resveratrol attenuates the progress of liver fibrosis via the Akt/nuclear factor-κB pathwaysMolecular Medicine Reports, 2015
- The Hippo pathway effector YAP controls mouse hepatic stellate cell activationJournal of Hepatology, 2015
- Liver fibrosis and repair: immune regulation of wound healing in a solid organNature Reviews Immunology, 2014
- A functional interaction between Hippo-YAP signalling and FoxO1 mediates the oxidative stress responseNature Communications, 2014
- Curcumin up‐regulates phosphatase and tensin homologue deleted on chromosome 10 through microRNA‐mediated control of DNA methylation – a novel mechanism suppressing liver fibrosisThe FEBS Journal, 2013
- The Hippo Signaling Pathway in Development and CancerDevelopmental Cell, 2010
- Anti-oxidant Effects of Resveratrol on Mice with DSS-induced Ulcerative ColitisArchives of Medical Research, 2010
- Mechanisms of Hepatic FibrogenesisGastroenterology, 2008
- Cancer Chemopreventive Activity of Resveratrol, a Natural Product Derived from GrapesScience, 1997